Chancery Rejects DMK Investor's Bid To Bar Annual Meeting
A DMK Pharmaceuticals stockholder lost another round Thursday in a long-running, pro se fight with the company's board and management, with the Delaware Court of Chancery rejecting his bid for a...To view the full article, register now.
Already a subscriber? Click here to view full article